ascorbic acid/inflammation

TECHNICAL FIELD The present invention relates to novel and useful L-ascorbic acid-2-O-maleic acid-.alpha.-tocopherol diester.1-propanol adduct or pharmacologically acceptable salts of the same, to processes for producing the same and to uses of the same as a cosmetic component or ingredient,

INTRODUCTION TO THE INVENTION The present invention relates to analgesic and anti-inflammatory medicine. Of particular interest is a composition containing ascorbic acid and/or its derivatives and aspirin and/or its derivatives. The present invention also relates to a method for reducing the side

TECHNICAL FIELD The present invention relates to an anti-inflammation analgesic preparation. More specifically, it relates to an anti-inflammation analgesic preparation which exhibits an excellent anti-inflammation analgesic effect on pains involving a swelling of a muscle, a joint or a bone and a

BRIEF DESCRIPTION OF THE INVENTION This invention relates to the combination of 25-hydroxyvitamin D ("25-OH D3" and/or "25-OH D2") and antioxidants/anti-inflammatories (ascorbic acid, Vitamin E and a carotenoid) for use in human nutraceuticals, pharmaceuticals and food supplements. This combination

BRIEF DESCRIPTION OF THE INVENTION This invention relates to the combination of 25-hydroxyvitamin D ("25-OH D3" and/or "25-OH D2") and antioxidants/anti-inflammatories (ascorbic acid, Vitamin E and a carotenoid) for use in bovine feed. This combination of nutritional supplements can contribute to

BACKGROUND OF THE INVENTION The present invention relates generally to methods of treatment and products for treating disorders. More specifically, the present invention relates to methods and compositions for preventing, treating or providing relief from inflammation of the joints, osteoarthritis,

BACKGROUND AND SUMMARY OF THE INVENTION The present invention relates to tissue degenerative inflammatory diseases, specifically periodontal disease and osteoarthritis, and to the prevention, treatment and amelioration thereof, employing a novel combination of natural substances for such

BACKGROUND OF THE ART Skin is composed of a top layer, the epidermis, which is approximately 20 cell layers or about 0.1 mm in thickness, and a lower layer, the dermis, which is from about 1 to about 4 mm in thickness and contains small blood vessels, collagen, elastin and fibroblasts. The dermis

BACKGROUND This invention relates to a mixture of natural ingredients for the treatment of bone or joint inflammation. Bone and joint inflammation is a scourge of both animals and humans. Examples of this debilitating condition include arthritis, including rheumatoid arthritis, rheumatism,

BACKGROUND OF THE INVENTION The present invention relates to ascorbyl esters, which are conjugates of ascorbic acid with certain sugar lactones; in their optically active, inactive, or racemic forms (such as d, l, dl, and meso); wherein ascorbyl moiety provides the alcohol part, and the sugar

BACKGROUND OF THE INVENTION Throughout this application various patents and publications are referenced and citations are provided in parentheses. The disclosure of these patents and publications in their entireties are hereby incorporated by reference into this application in order to more fully

FIELD OF THE INVENTION The invention is directed to a method for reducing irritancy of an ascorbic acid composition for anti-angiogenic and other effects. BACKGROUND OF THE INVENTION Many substances are commonly applied to the skin, mucosal tissue and to other tissues of humans and animals to treat

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a triple action complex containing three types of vitamin C that is used for treatment of the skin. 2. Discussion of the Prior Art There have been a variety of substances that have been used to improve skin

TECHNICAL FIELD The present invention relates to novel oral dosage forms that protect the epithelial and mucosal tissues of the mouth and the buccal cavity, the pharynx, the larynx, and the esophagus from erosion, ulceration, or other like irritation suffered by direct contact of these tissues with

TECHNICAL FIELD The present invention relates to novel oral dosage forms that protect the epithelial and mucosal tissues of the mouth and the buccal cavity, the pharynx, the larynx, and the esophagus from erosion, ulceration, or other like irritation suffered by direct contact of these tissues with